Mid-Size European pharma replaced legacy system by RxLogix NextGen Safety Platform. - Rxlogix Mid-Size European pharma replaced legacy system by RxLogix NextGen Safety Platform. - Rxlogix

Mid-Size European pharma replaced legacy system by RxLogix NextGen Safety Platform.

Mid-Size European pharma replaced legacy system by RxLogix NextGen Safety Platform.

17 Dec 2025

Problem Statement​:

  • Lack of automation in case intake and case processing
  • Multiple database and multiple applications were used within Safety Department (ARISg, Spotfire, reporting tools). Company wanted integrated platform.
  • Performance challenges with the Aggregate report generation.
  • Lack of automation in ICSR submissions and distribution.
  • Expensive and inadequate vendor support for maintaining safety system.

Solution Implemented:

  • Replaced ArisG, IRT, Spotfire, Legacy Reporting Tool with RxLogix’s Safety-in-a-Box (PV Case Management, PV Reports & PV Central)
  • Case form automation using ML/AI
  • Implementation of PV Gateway for automated electronic submission
  • Multiple Ad-hoc reports were created to streamline and provide oversight of PV operations
  • Workflow for Global and Local Case Processing and submissions – NMPA (Chinese Agency)

400K+Cases for Migration​ | 30+Adhoc & Aggregate Reports | 100+Concurrent Users​ | 30+ICSR Destinations

Milestone achieved:

  • Achieved 80-90% automation in case entry through AI/ML-powered data extraction.
  • Eliminated costly maintenance overhead by transitioning of multiple applications to single RxLogix’s SIAB solution
  • Resolved performance bottlenecks in aggregate report generation
  • Decreased dependency on vendor support